I'm not sure that's entirely correct. The first timeline we saw for azer-cel (at the time of purchase) targeted Q3 2024 for a Phase 1b readout, so 2H 2024 is still accurate.
The more recent JPM slides show 2 updates for azer-cel across 2024 one in Q2 (enrolment) and one in Q3 (readout). So I don't think the timeline there has slipped at all?
And as far as no immediate updates, I would think, given Vaxinia's preliminary enrolment update of April 24 '24, that the next data cut would not be too far off. To speculate, I *think* they would want to see all Cohort 5 patients cross the 42 day mark first. So as of April 24, there are still 7 Cohort 5 patients that have not yet had their 42 day scan.
Perhaps June for the next cut? Or maybe we're lucky and will see something mid May.
GLTAH.
- Forums
- ASX - By Stock
- IMU
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-39
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.5¢ |
Change
-0.004(6.78%) |
Mkt cap ! $402.5M |
Open | High | Low | Value | Volume |
6.0¢ | 6.1¢ | 5.5¢ | $2.515M | 44.29M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 819340 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 515951 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 736340 | 0.055 |
29 | 2959163 | 0.054 |
17 | 1584508 | 0.053 |
19 | 1719511 | 0.052 |
22 | 3589607 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 515951 | 4 |
0.057 | 1117035 | 10 |
0.058 | 1866575 | 10 |
0.059 | 2264940 | 6 |
0.060 | 1912026 | 16 |
Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |